Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 28, 2019

View Archived Issues

Forward genetics identifies new immune player

Reversible, selective, potent BTK inhibitors identified by Tethering-fragment-based screening

Immunogenicity and efficacy animal studies of a new vaccine against Lassa virus confirm protection

hIL-12 gene therapy can prolong survival in recurrent high-grade glioma patients

FDA clears IND for long-acting injectable antipsychotic based on MedinCell technology

Permanent chemotherapy-induced baldness modeled

Conditional deletion of Talpid3 produces mouse model of Joubert syndrome

Arvinas initiates first-in-human study of ARV-471

Spago Nanomedical initiates first clinical trial of SN-132D

2-75, a novel enzalutamide-HDAC inhibitor hybrid with efficacy in models of prostate cancer

Adaptimmune, Noile-Immune announce collaboration to develop next-generation SPEAR T-cell products

New selective and potent class I HDAC inhibitor from Merck activates HIV latency ex vivo

Japan Tobacco discloses pyruvate dehydrogenase kinase inhibitors

Asahikawa Medical University, Hokkaido University patent echinomycin derivatives

Lilly discovers TRPA1 antagonists

New polycomb protein EED inhibitors identified at Mirati Therapeutics

Boehringer Ingelheim describes new ghrelin O-acyltransferase inhibitors

Bristol-Myers Squibb presents discovery of lupus candidate BMS-615

IRLAB to prioritize L-dopa-induced dyskinesia indication in development of IRL-790

Kintai Therapeutics announces academic collaborations in cancer

Genisphere collaborates with University Hospitals in pancreatic cancer

FDA approves Nourianz for Parkinson's disease

European Commission approves Soliris for neuromyelitis optica spectrum disorder

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...